Pfizer Reports Strong Q1 Revenue and Profit Growth
Pfizer reported first-quarter revenue of $14.5 billion for 2026, exceeding estimates by beating Wall Street's expectations with a 5% year-over-year increase driven primarily by strong performance in its launched and acquired products. The company reaffirmed its full-year financial outlook despite declines in pandemic-era product sales.
Topics: pharmaceuticals product_performance profitability revenue_growth